• Ping Liu, Lingli Deng, Lijun Yang, Xianhong Yuan, Wei Xia, and Yongxue Su.
• Department of Radiology.
• Medicine (Baltimore). 2020 Dec 11; 99 (50): e23419.

BackgroundThis study will evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) to investigate tumor resectability at primary debulking surgery among women experiencing advanced-stage ovarian cancer.MethodsWe will systematically search the randomized controlled trials (RCTs) for potentially eligible studies from electronic databases, including 4 English databases (PubMed, EMBASE, Web of Science, and Cochrane Library) and 3 Chinese databases (China National Knowledge Infrastructure, WanFang, and China Biomedical Database). The study language will be restricted to English and Chinese. Also, 2 independent authors will collect and carry out data extraction as well as quality assessment. Data will be synthesized using appropriate statistical methods.ResultsWe will summarize present study's evidence to assess the diagnostic accuracy of MRI for evaluating tumor resectability at primary debulking surgery in women experiencing advanced-stage ovarian cancer.ConclusionThe present study will put forward the latest high-quality evidence for MRI's clinical application for evaluating tumor resectability in women experiencing advanced ovarian cancer.Ethics And DisseminationSince the present study is a systematic review and meta-analysis based on the published literature, ethical approval will not be necessary.Protocol Registration NumberDOI 10.17605/OSF.IO/UWDRF (https://osf.io/uwdrf/).

28 keywords...

hide…